An observational study in Postoperative Acute Kidney Injury and Intraoperative Hypotension, sponsored by Lanyue Zhu. Active, not recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.
Sponsored by Lanyue Zhu · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 168 studies in Acute Kidney Injury with a site in China — 46 open to participants now, 54 under way, 1 of them phase 3. Acute Kidney Injury · China.
Among the 168 studies in Acute Kidney Injury with a site in China, this one is the 6th largest by planned enrollment of the 105 observational ones that give a count, is one of 10 that started in 2025, is one of 105 observational ones, reaches primary completion later than 21 of the 53 other live ones, and was the 139th registered.
1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.
Browse Acute Kidney Injury studies →46 of the 168 studies in Acute Kidney Injury with a site in China are open now. Recruiting first, the newest first:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Sites in China
Ages 18+
China National Center for Cardiovascular Diseases · Sites in China
Ages 18+
Jinling Hospital, China · Sites in China
Ages 18–75
Sir Run Run Shaw Hospital · Sites in China
Ages 18+
China National Center for Cardiovascular Diseases · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
168 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 11 · Phase 3 3 · Phase 4 10
First in 2004; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 44,504 is above the median of 160 across 814 observational studies indexed under Acute Kidney Injury.
Median enrollment 152 across the 63 interventional studies, 472 across the 105 observational. Of the 82 that completed or were terminated, 4 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 168 have an industry lead sponsor. The 10 most frequent:
Lanyue Zhu is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Lanyue Zhu has 2 studies filed under Acute Kidney Injury — fewer than ten, so there is no comparison to draw.
19 of the studies in Acute Kidney Injury with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07850947Second Affiliated Hospital, Zhejiang University, School of MedicineAn Observational Study of Percutaneous Glomerular Filtration Rate (TGFR) in the Early Warning of Contrast-induced Acute Kidney Injury During the Peri-examination Period of Emergency Enhanced CT | 2026-12 |
| NCT07672860Jinling Hospital, ChinaPerioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors | 2026-12 |
| NCT07602465Zhongda HospitalThe Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury | 2026-12-01 |
| NCT06939387Zhejiang Provincial People's HospitalDrug-induced Kidney Injury Model | 2026-12-30 |
| NCT04789733The Cleveland ClinicThe GUARDIAN Pilot Trial | 2026-12-31 |
Add all 19 to your calendar (.ics) → With an account.
Among the 168 studies in Acute Kidney Injury with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Postoperative acute kidney injury (AKI) is a serious complication often linked to low blood pressure during surgery. This study aims to better protect patients' kidneys by personalizing how blood pressure is managed during an operation.
The project has two main goals:
First, researchers will analyze data from over 44,000 past surgeries to identify which specific blood pressure measurements are the most critical warning signs for kidney damage.
Second, using this knowledge, they will build a smart tool (a machine learning model) to predict a unique, safe blood pressure target for each individual patient before their surgery begins.
This personalized approach is intended to give doctors a specific target to maintain during surgery, helping to prevent kidney injury and improve patient safety.
Study Rationale Postoperative Acute Kidney Injury (AKI) is a common and severe complication following non-cardiac surgery, leading to prolonged hospital stays, increased medical costs, and a higher risk of persistent kidney failure or death. Intraoperative hypotension (abnormally low blood pressure during surgery) is recognized as a significant contributor to AKI, as it can reduce blood flow and oxygen supply to the kidneys.
Currently, there is no clinical consensus on which component of blood pressure-such as systolic (SBP), diastolic (DBP), or mean arterial pressure (MAP)-is the most critical to monitor for preventing organ injury. Furthermore, current guidelines often recommend a universal "one-size-fits-all" threshold for hypotension (e.g., MAP \< 65 mmHg). This approach fails to account for individual patient differences, such as baseline blood pressure and co-existing health conditions, which may mean that the optimal blood pressure target varies significantly from person to person.
This study aims to address these gaps by using a large, multi-center dataset to first identify the most critical blood pressure components linked to AKI and then to develop a tool that predicts a personalized, optimal blood pressure threshold for individual patients.
This study is divided into two parts:
Part 1: Risk Assessment and Blood Pressure Component Analysis
Part 2: Development of a Personalized Prediction Model
Secondary Objectives:
To build a machine learning model that predicts a patient's risk of developing postoperative AKI based on their preoperative data.
②To explore the relationship between the cumulative 5-minute lowest intraoperative blood pressure and postoperative AKI, using this relationship to refine the predictive model.
3. Study Design and Methods This is a retrospective, multi-center cohort study.
Data Sources: The study will utilize de-identified electronic health record data from several large sources: the public INSPIRE database, Zhongda Hospital affiliated with Southeast University (2013-2024), Nanjing First Hospital (2016-2024), and the First Affiliated Hospital of Anhui Medical University (2013-2023).
Study Population: The study will include adult patients (age ≥ 18) who underwent non-cardiac surgery and had available intraoperative blood pressure monitoring data. An initial dataset of approximately 850,000 surgical records will be screened, with an estimated final cohort of 44,504 eligible patients after applying inclusion and exclusion criteria. Key exclusions include patients with pre-existing severe chronic kidney disease, those undergoing urological or kidney-related surgeries, and procedures with a short duration of anesthesia (\<60 min).
In Part 1, the research team will use unsupervised clustering methods (e.g., K-means) to group patients based on preoperative characteristics. Subsequently, multivariable logistic regression models will be used to analyze the association between intraoperative hypotension metrics and the risk of postoperative AKI/AKD within the overall cohort and across the different patient clusters.
In Part 2, machine learning algorithms, including XGBoost and Random Forest, will be employed to develop a series of predictive models. The final model will be designed to dynamically adjust a patient's hypotension threshold by iteratively calculating the AKI risk until it falls below a predefined safety level (10%). The model's performance will be rigorously evaluated using metrics such as the Area Under the Curve (AUC), and its interpretability will be assessed using SHAP (Shapley Additive Explanations) analysis.
All non-cardiac surgery data from INSPIRE database and all non-cardiac surgery data from 2013-2024 in Zhongda Hospital Southeast University, 2016-2024 in Nanjing First Hospital and 2013-2023 in Anhui Medical University Affiliated First Hospital were selected.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Postoperative AKI
KDIGO criteria for diagnosis (≥0.3 mg/dL or ≥1.5-fold increase in creatinine value)
Time frame: Within 7 days post-op
Individualized Optimal Intraoperative Hypotension Threshold.
A patient-specific blood pressure threshold predicted by a dynamic machine learning model. This threshold is identified as the blood pressure value at which the model-predicted risk of postoperative Acute Kidney Injury (AKI) falls below 10%.
Time frame: preoperative period
Postoperative AKD
KDIGO criteria for diagnosis (≥0.3 mg/dL or ≥1.5-fold increase in creatinine value)
Time frame: Within 8-90 days post-op
length of hospital stay
the interval from the end of surgery to discharge
Time frame: Through hospital discharge, an average of 1 weak
Predicted Risk of Postoperative AKI.
The probability of developing postoperative AKI, as calculated by a machine learning model using preoperative baseline data. Measured by AUROC, AUPRC and Calibration Curve
Time frame: preoperative period
Predicted Lowest Intraoperative Blood Pressure.
The predicted cumulative 5-minute lowest intraoperative blood pressure value, generated by a machine learning model based on preoperative data. Measured by R2 and MAE
Time frame: preoperative period
Started Sep 2025 (actual). Primary completion is estimated for Dec 2026, 15 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lanyue Zhu